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Inhibition of autophagy in theca cells induces CYP17A1 
and PAI-1 expression via ROS/p38 and JNK signalling 
during the development of polycystic ovary syndrome. 
( 多嚢胞性卵巣症候群における卵巣莢膜層でのオートファ
ジー抑制は活性酸素-p38/JNK シグナル経路を介して
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Chapter 0. Abstract 
Polycystic ovary syndrome (PCOS) is a clinical syndrome characterized as hyperandrogenism, 
oligo/anovulation, and polycystic ovary. Insulin is involved in the pathogenesis of PCOS, but actual 
etiology of PCOS is still unknown. Autophagy is an intracellular system that degrades cytosolic 
proteins and organelles. Dysregulation of autophagy is involved in the pathogenesis of diabetes 
mellitus and nonalcoholic fatty liver disease which are associated with PCOS. But the relationship 
between autophagy and PCOS has not been clarified. In this study I found that the p62 and ubiquitin 
was significantly increased in theca cells of PCOS on immunohistochemistry. These findings suggest 
that autophagy is suppressed in the ovaries of PCOS. Using bovine theca cells as in vitro model, 
autophagy inhibition by palmitic acid and chloroquine increased p62 and ubiquitin protein levels and 
induce the expression of Cytochrome P450 17A1 (CYP17A1) and Plasminogen activator inhibitor 
type-1 (PAI-1) mRNA and Androstenedione (ASD) secretion. Furthermore, palmitic acid and 
chloroquine exposure significantly increased reactive oxygen species (ROS) and activated p38 and 
JNK signaling pathway. Inhibition of p38 and JNK signaling significantly reduced CYP17A1 and 
PAI-1 mRNA expression. In conclusion, I showed that the inhibition of autophagy in theca cells 
contributed the pathogenesis of PCOS, reading CYP17A1 and PAI-1 mRNA expression via 
ROS/p38 and JNK signaling pathway. 
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Chapter 1. Introduction 
Polycystic ovary syndrome (PCOS) is the most prevalent reproductive disorder causing 
anovulatory infertility. The prevalence rate is 8 to 13% in women of reproductive age (1). The 
Rotterdam diagnostic criteria for PCOS are internationally endorsed and are based on two of three 
features: oligo- or anovulation, hyperandrogenism (clinical or biochemical), and polycystic ovary 
(2). A considerable proportion of women with PCOS display insulin resistance (3), but the actual 
aetiology of PCOS is unknown. 
 Recent studies showed that cytochrome P450 17A1 (CYP17A1) and plasminogen activator 
inhibitor (PAI-1) play important roles in the pathogenesis of PCOS. CYP17A1, localized in theca 
cells, converts progesterone to 17α-hydroxy pregnenolone and then androstenedione (ASD) by 17α-
hydroxylase and C17-20 lyase activities (4, 5), and CYP17A1 expression in theca cells in PCOS 
women is up-regulated (6). Therefore, CYP17A1 in theca cells plays an important role in 
hyperandrogenism in the pathogenesis of PCOS (7). 
 PAI-1 is a molecule that prevents plasminogen activation driven by tissue plasminogen activator (t-
PA) and urokinase plasminogen activator (u-PA) (8, 9). In normal ovarian physiology, the 
plasminogen system allows for a window of t-PA excess, which causes the conversion of 
plasminogen to plasmin within the follicular fluid and ultimately results in proteolytic breakdown of 
the follicular wall and ovulation (10). Interestingly, Devin et al. reported that transgenic mice that 
constitutively express a stable form of human PAI-1 exhibit a hypertrophied theca layer with 
fibrosis, a characteristic of human PCOS ovaries (11). In other words, PAI-1 plays important roles in 
the fibrosis of PCOS ovaries. However, the cause of PAI-1 upregulation is unclear. 
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 Autophagy is an intracellular system that degrades cytosolic proteins and organelles (12, 13), 
maintaining cell and tissue homeostasis by digesting unwanted or damaged components, recycling 
materials, and producing energy. Dysregulation of autophagy has been shown to be involved in the 
pathogenesis of human metabolic diseases, such as diabetes mellitus (DM) and non-alcoholic fatty 
liver disease (NAFLD) (14, 15). Although these metabolic diseases are strongly associated with 
PCOS (16, 17), the relationship between autophagy and PCOS is unknown. Hence, I investigated (1) 
the activity of autophagy in PCOS ovaries and (2) the role of autophagy in androgen production and 
fibrosis in vitro. 
 
Chapter 2. Materials and methods 
2.1 Human specimens 
 Immunohistochemical analysis was performed on the ovaries of 4 PCOS and 4 control patients. 
Normal ovaries were obtained from women with regular menstrual cycles without hormonal 
treatment, who underwent radical or extended hysterectomy for cervical carcinoma. PCOS ovaries 
were obtained from woman diagnosed with PCOS according to the Rotterdam diagnostic criteria, 
who underwent extended hysterectomy or hysterectomy for endometrial carcinoma. All experimental 
procedures were approved by the University of Toyama review board. All methods were performed 
in accordance with the guidelines and regulations of the review board at the University of Toyama, 





Paraffin-embedded tissues were cut to 4 µm-thick sections and mounted on slides. Slides were 
deparaffinized in xylene, rehydrated through a graded series of ethanol, and washed in water. 
Antigen retrieval was performed in 10 mM sodium citrate buffer (pH 6.0) by microwaving for 10 
min and then cooling to room temperature. Slide staining with the first and second antibodies was 
performed according to the manufacturer’s instructions. The immunostaining was performed using 
specific antibodies to p62 (MBL, Nagoya, Japan, Cat# PM045, 1:200 dilution), ubiquitin (Cell 
Signaling Technology, MA, USA, Cat# 3936, 1:800 dilution) and PAI1 (Abcam, Cambridge, UK, 
Cat# ab66705, 1:200 dilution). The tissues were also stained with Azan Mallory. The percent of 
fibrotic tissue in the interstitial area was analyzed using ImageJ software. All micrographs were 
taken with a BZ-X810 microscope (Keyence, Osaka, Japan). 
 
2.3 Theca cell culture 
 Bovine ovaries were collected immediately after slaughter at a local abattoir. The ovaries were 
placed in an ice-cold buffered salt solution and transferred to the laboratory less than 90 min after 
collection. Theca cells were isolated from the ovaries under sterile conditions, as described 
previously (18). Briefly, small antral follicles (2-5 mm diameter) with a clear surface were cut into 
halves, and the theca interna was removed in situ using fine forceps. The resultant thin thecal layer 
was minced and subsequently treated with high-glucose Dulbecco’s Modified Eagle Medium 
(DMEM) (Thermo Fisher Scientific, MA, USA) containing 2.5 mg/ml collagenase (Fujifilm Wako 
Pure Chemical, Osaka, Japan), 0.4 IU/ml DNase (Invitrogen, CA, USA), 10% (v/v) foetal bovine 
serum (FBS) (Sigma-Aldrich, MO, USA), and 1% (v/v) penicillin-streptomycin-amphotericin B 
suspension (PSA) (Fujifilm Wako Pure Chemical). Isolated theca cells were grown in high-glucose 
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DMEM supplemented with 10% FBS and 1% PSA for 24—48 h. Twenty-four hours before 
performing the experiments, theca cells were placed in low-serum DMEM containing 1% FBS and 
1% PSA.  
 
2.4 Palmitic acid (PA) treatment 
 Bovine serum albumin (BSA)-conjugated PA was prepared as previously reported (19). Briefly, 
palmitic acid (P0500, Sigma-Aldrich) was dissolved in 95% (v/v) ethanol at 60℃ to yield a stock 
concentration of 100 mM, conjugated with BSA (Cat# 01281-26, Nacalai Tesque, Kyoto, Japan) at a 
3:1 molar ratio, and incubated for 1 h at 37℃. Theca cells were treated with or without PA for 24 h. 
In the experiments studying the role of p38 or JNK, theca cells were stimulated with PA in the 
absence or presence of the p38 inhibitor (10 µM, SB202190, Sigma-Aldrich) or JNK inhibitor (20 
µM, SP600125, Sigma-Aldrich) for 30 min before adding PA. 
 
2.5 Reverse transcription (RT) and quantitative real-time polymerase chain reaction (PCR) analysis 
 Total RNA was extracted from the theca cells using an ISOGEN-II (Nippon Gene, Tokyo, Japan). 
RT was performed using Rever Tra Ace qPCR RT Master Mix with gDNA Remover (Toyobo. 
Tokyo, Japan). Approximately 0.5–1 µg of total RNA was reverse-transcribed in a 20-µL volume. 
For the quantification of various mRNA levels, real time PCR was performed using the Mx3000P 
Real-time PCR System (Agilent Technologies, CA, USA) according to the manufacturer’s 
instructions. The PCR primers used with the SYBR Green methods were selected from different 
exons of the corresponding genes to discriminate PCR products that might arise from possible 
chromosomal DNA contaminants. The SYBR Green thermal cycling conditions were 1 cycle of 
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95℃ for 30 s, and 40 cycles of 95℃ for 10 s, 60℃ for 10 s, and 72℃ for 10 s. The relative 
mRNA levels were calculated using the standard curve method and were normalized to the mRNA 
levels of beta-actin (forward, 5′-GCAGGAGTACGATGAGTCCG -3′ and reverse, 5′-
TGTCACCTTCACCGTTCCAG-3′). The primer sequences used for RT-PCR were as follows: 
CYP17A1 (forward, 5′-GATCGGTTTATGCCTGAGCG-3′ and reverse, 5′-
CATGGGATCCGGGACGTTAG-3′) and PAI-1 (forward, 5′-CTGCGAAATTCAGGATGCGG-
3′ and reverse, 5′-GGGTGAGAAAACCACGTTGC-3′). 
 
2.6 Western blot analysis 
 Treated cells were lysed with lysis RIPA buffer (Cat# 182-02451, Fujifilm Wako Pure Chemical) 
containing complete protein inhibitor (Cat# 11697498001, Roche, Basel, Switzerland) and 
phosphatase inhibitor cocktail 2 (Cat# P5726, Sigma-Aldrich). The protein concentration of the 
sample was measured by the Bradford assay using quick start Bradford (Cat# 500-0205, Bio-Rad, 
CA, USA). An equal amount of protein (20-30 µg) was resolved on 10% SDS-PAGE. Separated 
proteins were transferred onto a PVDF membrane (Cat# 162-0175, Bio-Rad), and then the 
membrane was blocked in 5% BSA (Cat# 01281-26, Nacalai Tesque) for 1 h and subsequently 
incubated with rabbit antibody to p62 (dilution; 1:1000, Cat# PM045, MBL), rabbit antibody to 
Microtubule-associated proteins 1A/1B light chain 3B (LC3-B) (dilution; 1:1000, Cat# NB100-
2220, Novus Biologicals), rabbit antibody to total p38 MAPK (dilution; 1:1000, Cat# 9212, Cell 
Signalling Technology, MA, USA), rabbit antibody to phosphor-specific (Thr180/Thr182) p38 
MAPK (dilution; 1:500, Cat# 9211, Cell Signalling Technology), rabbit antibody to total JNK 
MAPK (dilution; 1:1000, Cat# 9252, Cell Signalling Technology), rabbit antibody to phosphor-
 9 
specific JNK MAPK (dilution; 1:500, Cat# 4668, Cell Signalling Technology), or mouse antibody to 
beta-actin (ACTB, dilution; 1:2000, Cat# 3700, Cell Signalling Technology) as the primary antibody 
for 2 h. Then, menbranes were treated with the secondary anti-rabbit (dilution; 1:2000, Cat# 7074, 
Cell Signalling Technology) or anti-mouse (dilution; 1:2000, Cat# 7076, Cell Signalling 
Technology) IgG HRP-linked antibody for 1 h. Protein bands were detected by a chemiluminescence 
assay using SuperSignal (Cat# 34580, Thermo Fisher Scientific). The bands were finally quantified 
using NIH ImageJ software. 
 
2.7 ASD assay 
The bovine ASD concentration in cell culture supernatants was measured by the Androstenedione 
ELISA Kit (Abnova, Taipei, Taiwan). The absorbance was measured at 450 nm using an iMark 
Microplate Absorbance Reader (Bio-Rad).  
 
2.8 Electron microscopy imaging 
Bovine theca cells were immersion fixed in 2% (v/v) glutaraldehyde (0.1 M phosphate buffer, pH 
7.4) for 60 min. Samples were post-fixed in 1% osmium tetroxide for 60 min at 4 ℃, dehydrated in 
graded alcohol, embedded in 100% epoxy resin (Nisshin EM, Tokyo, Japan) in beam capsules, and 
allowed to harden in a 65℃ oven for 48 h. After hardening, epoxy resin blocks were ultrathin-
sectioned at a 100 nm thickness and placed on 150 mesh copper grids. Grids were next 
counterstained with saturated uranyl acetate and lead citrate and then viewed and imaged at X1500-




2.9 Measurement of reactive oxygen species (ROS) in bovine theca cells 
Intracellular ROS generation was detected using a CellROX Green Reagent (Thermo Fisher 
Scientific) fluorescent probe. Pretreated cells in 24-well plates were incubated with CellROX (5 
µmol/L) at 37°C for 60 min and then washed with PBS. The cell fluorescence was observed using a 
BZ-X810 (Keyence) and analysed by hybrid cell count module software/BZ-H4C (Keyence). 
 
2.10 Statistical analysis 
 All experiments were repeated at least three times. Non-normally distributed data were analysed by 
nonparametric tests (Mann-Whitney U test) using JMP software (SAS Institute Inc., Cary, NC, 
USA). A p-value <0.05 was considered statistically significant. 
 
Chapter 3. Results 
3.1 Autophagic turnover was impaired in ovaries from women with PCOS  
When autophagy is impaired, aggregated proteins are increased and tagged with p62 and ubiquitin 
(20). Therefore, to assess autophagy activity, I investigated the level of p62 and ubiquitin as markers 
of aggregated protein in human ovaries using immunohistochemistry. There was a significant 
increase in the frequency of cells that stained positive for p62 and the ubiquitin observed (p < 0.05) 
in theca cells and granulosa cells in the ovaries from women with PCOS compared with the control 
(Fig 1A and 1B). The intensity of immunostaining in theca cells was clearer than that in granulosa 
cells. These findings suggested that aggregated proteins accumulate in theca cells. Next, I examined 
the PAI-1 protein expression as a marker of fibrosis (21). The number of cells that stained positive 
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for PAI-1 was significantly increased (p < 0.05) in the theca cell layer in the PCOS cases compared 
with the control cases (Fig 1C). In addition, Azan staining revealed that the area of fibrotic tissue in 
the interstitium was significantly increased (p < 0.05) in PCOS cases compared to that in the control 
cases (Fig 1E). These findings suggested that elevated PAI-1 expression induced tissue fibrosis in the 
ovaries of women with PCOS.  
 
3.2 Palmitic acid impaired autophagic turnover in bovine theca cells 
I considered PA, one of the free fatty acids (FFAs), as a candidate substance to impair autophagic 
turnover, because PA is one of the main substances of lipotoxicity associated with metabolic 
syndrome and impairs autophagic turnover (15). It is ethically difficult to obtain human ovarian 
theca cells. Thus, I examined whether PA impaired autophagy in bovine theca cells in vitro. PA 
treatment significantly increased the p62 level (p < 0.05) and LC3-Ⅱ/LC3-Ⅰ ratio (p < 0.05) in a 
concentration-dependent manner (Fig 2A, 2B, and 2C). Elevation of the LC3-Ⅱ/LC3-Ⅰ ratio 
indicates not only autophagy activation but also inhibition of autophagosome degradation, which is a 
late-stage autophagy process (22). To clarify whether autophagy was activated or inhibited, I 
conducted the autophagy flux assay using chloroquine (CQ), which is an inhibitor of lysosome 
function and autophagy (23, 24). If the LC3-Ⅱ level is increased in the presence of lysosome 
inhibitors, this indicates that autophagy is activated. However, if the LC3-Ⅱ level is unchanged, 
this indicates that autophagosome accumulation occurred due to inhibition of autophagic 
degradation. Therefore, the LC3-Ⅱ ratio of no treatment with lysosomal inhibitor to treatment 
correctly shows autophagy activity (25). The autophagy flux assay revealed that the LC3-Ⅱ ratio 
was significantly decreased (p < 0.05) after PA treatment (Fig 2D and 2E), indicating inhibition of 
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autophagy turnover. These data clearly show that PA inhibited the late-stage autophagy 
autophagosome degradation steps. 
 
3.3 Palmitic acid increased CYP17A1 and PAI-1 mRNA expression and ASD secretion in bovine 
theca cells 
 Next, I examined whether PA induced a PCOS-like hormonal or cytokine environment by 
evaluating CYP17A1 and PAI-1 mRNA expression in bovine theca cells. CYP17A1 and PAI-1 
mRNA were significantly elevated (p < 0.05, p < 0.05) after PA-treatment compared to the control 
(Fig. 2F and 2G). Furthermore, secretion of ASD was significantly elevated (p < 0.05) in the culture 
supernatant of PA-treated bovine theca cells (Fig. 2H). These findings suggest that PA induced 
autophagy impairment and contributed to hyperandrogenism and fibrosis in ovaries. 
 
3.4 Inhibition of the late stage of autophagy by chloroquine-induced CYP17A1 and PAI-1 mRNA 
expression and ASD secretion 
  To clarify that autophagy impairment directly induces CYP17A1 and PAI-1 mRNA, and ASD 
secretion, I investigated whether CQ, an inhibitor of the late stage of autophagy (23), induced 
CYP17A1 and PAI-1 mRNA expression. CQ inhibited the late stage of autophagy because of the 
significantly increased p62 levels (p < 0.05) and LC3-Ⅱ/LC3-Ⅰ ratios (p < 0.05) by 50 µM of CQ 
treatment (Fig. 3A, 3B, and 3C). Furthermore, CQ treatment significantly elevated CYP17A1 (p < 
0.05) and PAI-1 (p < 0.05) mRNA in bovine theca cells (Fig. 3D and 3E). ASD secretion was also 
significantly elevated (p < 0.05) in the culture supernatant of CQ-treated theca cells (Fig. 3F). These 
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findings indicate that inhibition of the late stage of autophagy contributed to hyperandrogenism and 
fibrosis in ovaries. 
 
3.5 Palmitic acid disrupts mitochondria and induces ROS production 
 There are numerous reports about how impairment of autophagy induces mitochondria dysfunction 
and reactive oxygen species (ROS) production (26-28). Therefore, I examined whether inhibition of 
autophagy by PA injured mitochondria and induced ROS. Transmission electron microscopy (TEM) 
revealed that PA and CQ treatment in theca cells resulted in a reduction of electron density in 
intracellular vesicles compared with starvation-treated theca cells (Fig 4Ab, 4Ac, and 4Ad). 
Aggregated proteins and cytoplasmic organelles in autophagosomes are regularly digested by 
lysosomal enzymes. This finding indicated that PA treatment disrupted lysosomal function (29). 
TEM showed that mitochondria in PA-treated theca cells were crucially swelled compared with 
those in BSA and CQ treatment conditions (Fig 4Ae, 4Ag, and 4Ah), suggesting mitochondria 
dysfunction (30). Next, I assessed ROS production by the CellROX assay. This experiment revealed 
that ROS production was significantly elevated by PA and CQ treatment in theca cells compared 
with BSA-treated controls (Fig. 4B). 
 
3.6 p38 and JNK signalling pathways were involved in CYP17A1 and PAI-1 mRNA upregulation by 
PA and CQ treatment. 
 Stress-induced mitogen-activated protein kinases (SAPKs), JNK and p38, are activated by ROS in 
various cells (31, 32). Therefore, p38 and JNK might be key regulators of CYP17A1 and PAI-1 
expression in PA-treated bovine theca cells. Firstly, I assessed the phosphorylation of p38 and JNK. 
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PA treatment significantly increased the phosphorylation of p38 and JNK in a dose-dependent 
manner (Fig 5A and 5B) and in CQ-treated theca cells (Fig 6A and 6B). Next, I studied the effect of 
p38 and JNK signal pathways on CYP17A1 and PAI-1 mRNA in PA- and CQ-treated bovine theca 
cells. Inhibitors of p38 and JNK significantly attenuated not only CYP17A1 and PAI-1, but also 
ASD in PA-treated theca cells (Fig 5C, 5D, and 5E) and in CQ-treated theca cells (Fig . 6C, 6D, and 
6E). These data show that p38 and JNK are key regulators of CYP17A1 and PAI-1 mRNA 
upregulation following PA and CQ treatment. 
 
Chapter 4. Discussion 
In this study, I obtained two new important findings. First, p62 and ubiquitin, aggregated proteins 
and autophagy impairment markers, were accumulated in the theca cell layer of the PCOS ovary. 
Second, dysregulation of late-stage autophagy in theca cells induced CYP17A1 and PAI-1 mRNA 
upregulation and androgen secretion via the ROS/p38 and JNK signalling pathway. 
 I reported in this study for the first time that p62 and ubiquitin are accumulated in the theca cell 
layer in the ovaries in women with PCOS. This suggests that autophagy is impaired in the theca cell 
layer in PCOS, and accumulation of p62 and ubiquitin were observed in autophagy deficient mice 
(20). A Gonzalez-Rodriguez et al. reported that the late stage of autophagy is impaired in the livers 
of individuals with non-alcoholic steatohepatitis, which is related to PCOS (17). They showed that 
saturated free fatty acids (FFAs), especially PA, were assumed to be the cause of autophagy 
impairment (15). FFA also plays an important role in insulin resistance (33). In addition, PA is 
elevated in the serum and follicular fluid of PCOS patients and induces androgen production(34, 35). 
Therefore, it is possible that PA plays a part in the pathogenesis of PCOS. Our in vitro experiment 
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revealed that PA treatment of theca cells increased the p62 and LC3-Ⅱ/LC3-Ⅰ ratio. To distinguish 
whether autophagy was activated or inhibited, I investigated the autophagy flux assay, which 
measures LC3-Ⅱ accumulation in the presence of lysosomal function inhibitor (25). The autophagy 
flux assay showed that LC3-Ⅱ accumulation only increased in the control treatment group in the 
presence of CQ but not in the PA treatment group. These findings showed that PA impaired 
autophagic degradation in bovine theca cells, resulting in autophagosome accumulation. 
Secondly, I showed that impairment of late-stage autophagy in theca cells by PA and CQ treatment 
induced CYP17A1 and PAI-1 mRNA upregulation and androgen production via the ROS/p38 and 
JNK signalling pathway. Not only PA treatment but also CQ treatment increased CYP17A1 and PAI-
1 mRNA expression in bovine theca cells, leading to androgen production. It is well-known that 
inhibition of autophagy induces ROS(36-38) . ROS then activates p38 and JNK, which are known as 
stress-associated protein kinases in various cells (31, 32). The p38 and JNK signalling pathways play 
an important role in insulin resistance and fibrosis, typical findings in PCOS(39, 40) . PA and CQ 
treatment increased ROS production and phospho-p38 and JNK. Both p38 and JNK inhibitor 
strongly inhibited CYP17A1 and PAI-1 mRNA expression. These findings strongly indicate that p38 
and JNK are involved in the pathogenesis of PCOS. It is suggested that autophagy activation or ROS 
inhibition decrease CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling pathways. It is 
known that autophagy disorder and ROS induces endoplasmic reticulum (ER) stress (41, 42). 
Takahashi et al. reported that endoplasmic reticulum stress was elevated in the PCOS (43, 44). Thus, 
ER stress might be upregulated in our cellular model. Further studies are needed in order to explore 
these possibilities. 
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This study has three limitations. First, I could not assess autophagy activity in the ovaries of women 
with PCOS. In this study, I could only elucidate that aggregated proteins were increased in PCOS 
ovaries by evaluating p62 and ubiquitin. Second, I could explain the association between autophagy 
and PCOS only in vitro. To investigate the association between autophagy and PCOS in vivo, I 
should produce theca-cell specific autophagy deficient mice. Third, PA is also known to stimulate 
p38 and JNK through the TLR4 receptor (45, 46). Therefore, the activation of p38 and JNK were 
induced by not only autophagy inhibition but also the TLR4/p38 and JNK signalling pathway. 
Further studies are needed to address these limitations. 
This study clearly showed that aggregated proteins were increased in the theca cell layer of the 
PCOS ovary, and dysregulation of late-stage autophagy in theca cells induced androgen production 
and fibrosis via the ROS/p38 and JNK signalling pathway. Our study suggests that the ROS/p38 and 
JNK signalling pathway might be an important therapeutic target for PCOS. 
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Chapter 8. Figure legends 
Figure 1: P62, ubiquitin, and PAI-1 protein expression levels in the ovaries of control and PCOS 
patients determined by immunohistochemical analysis. (A-C) Cross-sections of ovaries were stained 
with an anti-p62, anti-ubiquitin, and anti-PAI-1 antibody and counterstained with hematoxylin. (D) 
Controls for background level stained with isotype IgG and hematoxylin. (E) Cross-sections of 
ovaries were stained with Azan stain. Fibrotic tissue was stained blue. (A-C, and E) (a-d) show the 
representative sections. Lower panels (c, d) show highly magnified views corresponding to (a, b). (e) 
The quantitative analysis of (A-C) immunohistochemical staining and (E) Azan staining. (D) Right 
panel (b) shows a highly magnified view corresponding to the left panel (a). The scale bars in (A-C, 
and E) (a, b) and (E) (a) indicate 200 µm, while those in (A-C, and E), (c, d), and (E) (b) indicate 50 
µm. *p < 0.05. GC, granulosa cell layer; TC, theca cell layer; NC, negative control. 
 
Figure 2: Effects of PA on autophagy and Cyp17A1 and PAI-1 mRNA expression in theca cells. (A) 
Representative western blot analysis of p62 and LC3-Ⅱ/LC3-Ⅰ in theca cells treated with different 
doses of PA (100, 200, and 500 µM) for 24 h. (B and C) Densitometric analysis of p62 and LC3-Ⅱ
/LC3-Ⅰ ratio. (D and E) The autophagy flux assay. Theca cells treated with 200 µM PA for 24 h in 
the absence or presence of 50 µM Chloroquine (CQ) for the last 2 h were subjected to 
immunoblotting. (D) Representative western blot analysis of p62 and LC3-Ⅱ/LC3-Ⅰ. (E) LC3 flux 
was assessed by subtracting the amount of LC3-Ⅱ in the absence of CQ from the amount of LC3-
Ⅱ in the presence of CQ for each of the conditions. CYP17A1 (F) and PAI-1 (G) mRNA expression 
in theca cells treated with different doses of PA (100, 200, and 500 µM) for 24 h. (H) ASD in the 
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culture supernatant was measured by ELISA. *p < 0.05. Data are expressed as the mean ± SEM (n = 
4 in each experiment). 
 
Figure 3: Effect of CQ on autophagy and Cyp17A1 and PAI-1 mRNA expression in bovine theca 
cells. (A) Representative western blot analysis of p62 and LC3-Ⅱ/LC3-Ⅰ in theca cells treated 
with different doses of CQ (10, 20, and 50 µM) for 24 h. (B and C) Densitometric analysis of p62 
and LC3-Ⅱ/LC3-Ⅰ ratio. (D and E) CYP17A1 and PAI-1 mRNA expression in theca cells treated 
with different doses of CQ (10, 20, and 50 µM) for 24 h. (F) ASD in the culture supernatant was 
measured by ELISA. *p < 0.05. Data are expressed as the mean ± SEM (n = 4 in each experiment). 
 
Figure 4: Transmission electron microscopy (TEM) images and assessment of ROS production. (A) 
Representative TEM images from theca cells treated with control condition (a, e), starvation 
condition for 2 h (b, f), 200 µM PA for 24 h (c, g), or 20 µM CQ for 24 h (d, h). Lower panels (e, f, 
g, h) show highly magnified views corresponding to (a, b, c, and d). (B) Representative fluorescence 
images of intracellular ROS measured using CellROX Oxidative Stress Reagents in theca cells 
treated with control conditions (a), 200 µM PA for 24 h (b), or 20 µM CQ for 24 h (c). (d) 
Quantitative analysis was performed (n = 5). *p < 0.05. Data are expressed as the mean ± SEM.  
 
Figure 5: The involvement of p38 and JNK pathway in the effects of PA. Representative western blot 
analysis and densitometric analysis of p38 (A) and JNK (B) in theca cells treated with different 
doses of PA (100, 200, and 500 µM) for 24 h. CYP17A1 (C) and PAI-1 (D) mRNA expression in 
theca cells incubated with 200 µM PA for 24 h in the absence or presence of 10 µM p38 inhibitor 
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(SB202190) and 20 µM JNK inhibitor (SP600125). (E) ASD in the culture supernatant was 
measured by ELISA. *p < 0.05. Data are expressed as the mean ± SEM (n = 4 in each experiment). 
 
Figure 6: The involvement of the p38 and JNK pathway in the effects of CQ. Representative western 
blot analysis and densitometric analysis of p38 (A) and JNK (B) in theca cells treated with different 
doses of CQ (10, 20, and 50 µM) for 24 h. CYP17A1 (C) and PAI-1 (D) mRNA expression in theca 
cells incubated with 20 µM CQ for 24 h in the absence or presence of 10 µM p38 inhibitor 
(SB202190) and 20 µM JNK inhibitor (SP600125). (E) ASD in the culture supernatant was 
measured by ELISA. *p < 0.05. Data are expressed as the mean ± SEM (n = 4 in each experiment). 
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